Health research systems: Promoting health equity or economic competitiveness?;Sistemas de investigación sanitaria: ¿promoción de la igualdad sanitaria o competitividad económica?

Bulletin of the World Health Organization

Volumn 90, Issue 1, 2012, Pages 55-62

  Pratt, Bridget ^a   Loff, Bebe ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPETITIVENESS; DEVELOPING WORLD; ECONOMIC IMPACT; HEALTH CARE; HEALTH POLICY; LEGISLATION; NATIONAL ECONOMY; RESEARCH; RESEARCH AND DEVELOPMENT; STATE ROLE;

ARTICLE; CLINICAL TRIAL (TOPIC); DEVELOPING COUNTRY; DRUG RESEARCH; FUNDING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH DISPARITY; HIGH INCOME GROUP; INVESTMENT; LAW; MEDICAL RESEARCH; PUBLIC-PRIVATE PARTNERSHIP; SOCIAL STATUS; TAX; UNITED KINGDOM; UNITED STATES;

UNITED KINGDOM; UNITED STATES;

EID: 84855283453     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.11.092007     Document Type: Article

References (50)

1. Health research: essential link to equity in development. Oxford: Commission on Health Research for Development; 1990.
2. Bamako call to action on research for health. Bamako, Mali: Global Ministerial Forum on Research for Health; 2008.
3. The Millennium Development Goals will not be attained without new research addressing health system constraints to delivering effective interventions. Geneva: WHO Task Force on Health Systems Research; 2005.
4. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS; Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet 2003;362:65-71. doi:10.1016/S0140-6736(03)13811-1 PMID:12853204
5. The Millennium Development Goals for health: rising to the challenges. Washington: The World Bank; 2004.
6. The Mexico statement on health research. Mexico City: Ministerial Summit on Health Research; 2004.
7. Health research for the Millennium Development Goals. Geneva: Global Forum for Health Research; 2005.
8. Monitoring financial flows for health research 2008. Geneva: Global Forum for Health Research; 2008.
9. Bennett S, Adam T, Zarowsky C, Tangcharoensathien V, Ranson K, Evans T et al.; Alliance STAC. From Mexico to Mali: progress in health policy and systems research. Lancet 2008;372:1571-8. doi:10.1016/S0140-6736(08)61658-X PMID:18984191
10. Leroy JL, Habicht JP, Pelto G, Bertozzi SM. Current priorities in health research funding and lack of impact on the number of child deaths per year. Am J Public Health 2007;97:219-23. doi:10.2105/AJPH.2005.083287 PMID:17194855
11. Strengthening health systems in developing countries: the promise of research on policy and systems. Geneva: Alliance for Health Policy and Systems Research; 2004.
12. Allotey P, Reidpath DD, Ghalib H, Pagnoni F, Skelly WC. Efficacious, effective, and embedded interventions: implementation research in infectious disease control. BMC Public Health 2008;8:343. doi:10.1186/1471-2458-8-343 PMID:18826655
13. Zachariah R, Harries AD, Ishikawa N, Rieder HL, Bissell K, Laserson K et al. Operational research in low-income countries: what, why, and how? Lancet Infect Dis 2009;9:711-7. doi:10.1016/S1473-3099(09)70229-4 PMID:19850229
14. Sheikh K, Gilson L, Agyepong IA, Hanson K, Ssengooba F, Bennett S. Building the field of health policy and systems research: framing the questions. PLoS Med 2011;8:e1001073. doi:10.1371/journal.pmed.1001073 PMID:21857809
15. Slaughter S, Rhoades G. The emergence of a competitiveness research and development policy coalition and the commercialization of academic science and technology. Sci Technol Human Values 1996;21:303-39. doi:10.1177/016224399602100303
16. Excellence and opportunity: a science and innovation policy for the 21st century. Norwich: Department of Trade and Industry; 2000.
17. Science and innovation investment framework 2004-2014. Norwich: HM Treasury, Department for Education and Skills, Department of Trade and Industry; 2004.
18. Bouchard RA, Lemmens T. Privatizing biomedical research-a 'third way'. Nat Biotechnol 2008;26:31-6. doi:10.1038/nbt0108-31 PMID:18183013
19. Straw W. British innovation policy: lessons for the United States. Science Progress2009. Available from http://www.scienceprogress.org/2009/01/british-innovation-policy [accessed 18 Oct 2010]
20. Hopkins Tanne J. Industry is deeply involved in funding US research. BMJ 2003;326:179a-179. doi:10.1136/bmj.326.7382.179/a
21. Fisher JA. Medical research for hire: the political economy of pharmaceutical clinical trials. Rutgers: Rutgers University Press; 2009.
22. Etzkowitz H. The norms of entrepreneurial science: cognitive effects of the new university-industry linkages. Res Policy 1998;27:823-33. doi:10.1016/S0048-7333(98)00093-6
23. Medical Research Council annual report and accounts 2008/09. London: United Kingdom Medical Research Council; 2009.
24. Steinbrook R. Financial conflicts of interest and the NIH. N Engl J Med 2004;350:327-30. doi:10.1056/NEJMp038247 PMID:14736923
25. Cooksey D. A review of UK health research funding. London: The Stationary Office; 2006.
26. Siegel DS, Veugelers R, Wright M. Technology transfer offices and commercialization of university intellectual property: performance and policy implications. Oxf Rev Econ Policy 2007;23:640-60. doi:10.1093/oxrep/grm036
27. Moses H 3rd, Dorsey ER, Matheson DHM, Thier SO. Financial anatomy of biomedical research. JAMA 2005;294:1333-42. doi:10.1001/jama.294.11.1333 PMID:16174691
28. Kerner JF. Knowledge translation versus knowledge integration: a "funder's" perspective. J Contin Educ Health Prof 2006;26:72-80. doi:10.1002/chp.53 PMID:16557513
29. Woolf SH, Johnson RE. The break-even point: when medical advances are less important than improving the fidelity with which they are delivered. Ann Fam Med 2005;3:545-52. doi:10.1370/afm.406 PMID:16338919 strategy for international engagement in research and development. UK: Global Science and Innovation Forum; 2006.
30. Science and engineering indicators 2010. Arlington: National Science Foundation; 2010.
31. America's vital interest in global health: protecting our people, enhancing our economy and advancing our international interests. Washington: Institute of Medicine; 1997.
32. The US commitment to global health: recommendations for the public and private sectors. Washington: Institute of Medicine; 2009.
33. A strategy for international engagement in research and development. UK: Global Science and Innovation Forum; 2006.
34. Health is global: a UK government strategy 2008-13. Norwich: Department of Health; 2008.
35. Moran M, Guzman J, Ropars AL, Illmer A. The role of Product Development Partnerships in research and development for neglected diseases. In Health 2010;2:114-22. doi:10.1016/j.inhe.2010.04.002
36. Moran M. A breakthrough in R&D for neglected diseases: new ways to get the drugs we need. PLoS Med 2005;2:e302. doi:10.1371/journal.pmed.0020302 PMID:16138789
37. Moran M, Guzman J, Henderson K, Abela-Oversteegen L, Wu L, Omune B, et al. Neglected disease research and development: is the global financial crisis changing research? Sydney: Policy Cures; 2011.
38. Widdus R, White K. Combating diseases associated with poverty: financing strategies for product development and the potential role of public-private partnerships. Geneva: The Initiative on Public-Private Partnerships for Health; 2004.
39. Petryna A. When experiments travel: clinical trials and the global search for human subjects. Princeton, NJ: Princeton University Press; 2009.
40. Thiers FA, Sinskey AJ, Berndt ER. Trends in the globalization of clinical trials. Nat Rev Drug Discov 2008;7:13-4. doi:10.1038/nrd2441
41. Daar AS, Thorsteinsdóttir H, Martin DK, Smith AC, Nast S, Singer PA. Top ten biotechnologies for improving health in developing countries. Nat Genet 2002;32:229-32.doi:10.1038/ng1002-229 PMID:12355081
42. Juma C, Yee-Cheong L. Reinventing global health: the role of science, technology, and innovation. Lancet 2005;365:1105-7. PMID:15781106
43. Rudan I, El Arifeen S, Black RE, Campbell H. Childhood pneumonia and diarrhoea: setting our priorities right. Lancet Infect Dis 2007;7:56-61. doi:10.1016/S1473-3099(06)70687-9 PMID:17182344
44. Remme JHF. Research for control: the onchocerciasis experience. Trop Med Int Health 2004;9:243-54. doi:10.1046/j.1365-3156.2003.01192.x PMID:15040562
45. Hirschhorn LR, Ojikutu B, Rodriguez W. Research for change: using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings. J Infect Dis 2007;196(Suppl 3):S516-22. doi:10.1086/521120 PMID:18181704
46. Hutchinson E, Parkhurst J, Phiri S, Gibb DM, Chishinga N, Droti B et al. National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between context, evidence and links. Health Res Policy Syst 2011;9(Suppl 1):S6.doi:10.1186/1478-4505-9-S1-S6 PMID:21679387
47. Systems thinking for health systems strengthening. Geneva: World Health Organization; 2009.
48. Africa's science and technology consolidated plan of action. Addis Ababa: African Union; 2005. Available from: http://www.africa-union.org/root/UA/Annonces/HRST/Africa%20s%20Consolida ted%20Plan%20of%20Action.pdf [accessed 21 November 2011]
49. Science, technology and innovation policy initiative. Paris: United Nations Educational, Scientific and Cultural Organization; 2009. Available from: http://www.unesco.org/new/fileadmin/MULTIMEDIA/HQ/SC/pdf/sc_sti_initiati ve_africa_en.pdf [accessed 21 November 2011]
50. Science and technology cluster report. In: 11th session of the Regional Coordination Mechanism (RCM-Africa), Addis Ababa, Ethiopia, 14-15 November 2010. Paris: United Nations Educational, Scientific and Cultural Organization; 2010. Available from: http://www.uneca.org/rcm/RCM11/Science%20and%20Technology%20Cluster%20Re port.pdf [accessed 21 November 2011].